- 301. Magnocellular Nevus
- [A benign melanocytic proliferation within or adjacent to the optic disk. It presents as a pigmented, intraocular tumor. ( NCI )] (UMLS (NCI) C0334431) =Neoplastic Process
| - 351. Major Salivary Gland Sarcoma
- (UMLS (NCI) C1334553) Sarcoma of Major Salivary Gland;
Sarcoma of the Major Salivary Gland =Neoplastic Process |
- 302. MAGUK Family Gene
- [Membrane-Associated Guanylate Kinase Family Genes encode MAGUK (Membrane-Associated GUanylate Kinase homolog) proteins containing DHR, SH3, and C-terminal GK-like domains. MAGUKs include Drosophila lethal(1)discs large-1 tumor suppressor protein (dlg1); mammalian Zo-1 tight junction protein; mammalian synaptic proteins that seem to interact with the cytoplasmic tail of NMDA receptor subunits (SAP90/PSD-95, CHAPSYN-110/PSD-93, SAP97/DLG1 and SAP102); 55 kD erythrocyte membrane protein (p55); C. elegans lin-2 protein; rat CASK protein; and human DLG2 and DLG3 proteins. An N-terminal ATP-binding site (P-loop) of Guanylate Kinase is not conserved in the MAGUK GK-like domain; MAGUKs do retain residues known in GK to bind GMP. (NCI) ( NCI )] (UMLS (NCI) C1334692) Membrane-Associated Guanylate Kinase Family Gene;
=Gene or Genome | - 352. Makah Indian Tribe of the Makah Indian Reservation
- (UMLS (HL7) C1554365) =Population Group =NativeEntityContiguous;
|
- 303. Mahayana
- (UMLS (HL7) C1552051) =Idea or Concept =Religious Affiliation;
| - 353. Makarol
- (UMLS (NCI) C0699333) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
|
- 304. MAI Lymphadenitis
- (UMLS (NCI) C0858196) Mycobacterium Avium Intracellulare Lymphadenitis =Disease or Syndrome
| - 354. Make
- [A person, an enterprise, or an entity that produces finished goods. ( NCI )] (UMLS (NCI) C0947322) Maker;
Manufacturer; Manufacturer Name =Finding ; |
- 305. Maiden
- [A woman's surname before marriage. ( NCI )] (UMLS (NCI) C0806887) Maiden Name;
=Intellectual Product ; =Name type; | - 355. MAL HISTIOCYTOSIS ABDOM
- [ ] (UMLS (ICD9CM) C0432540) =Neoplastic Process
|
- 306. MAIDS
- [mouse model of AIDS. ( CSP )] (UMLS (NCI) C0079864) =Experimental Model of Disease =Retroviridae disease;
Tumor Virus Infections; acquired immunodeficiency; | - 356. MAL HISTIOCYTOSIS AXILLA
- [ ] (UMLS (ICD9CM) C0432541) =Neoplastic Process
|
- 307. Maiduan
- (UMLS (HL7) C1699746) =Language ;
=Penutian; =Mountain Maidu; Concow; Neeshenam; | - 357. MAL HISTIOCYTOSIS HEAD
- [ ] (UMLS (ICD9CM) C0432538) =Neoplastic Process
|
- 308. Mail
- (UMLS (HL7) C1547565) =Idea or Concept =Authorization Mode;
| - 358. MAL HISTIOCYTOSIS INGUIN
- [ ] (UMLS (ICD9CM) C0432542) =Neoplastic Process
|
- 309. Mail Claim Party
- (UMLS (HL7) C1550412) =Classification =HL7 Vocabulary Version 2.5;
=Employer; Guarantor; Insurance Company; Other; Patient | - 359. MAL HISTIOCYTOSIS MULT
- [ ] (UMLS (ICD9CM) C0432545) =Neoplastic Process
|
- 310. Mailing
- (UMLS (HL7) C1549634) =Idea or Concept =Address type;
| - 360. MAL HISTIOCYTOSIS PELVIC
- [ ] (UMLS (ICD9CM) C0432543) =Neoplastic Process
|
- 311. Mailto
- [Electronic mail address [RFC 2368]http://www.ietf.org/rfc/rfc2368.txt . ( HL7V3.0 )] (UMLS (HL7) C1555014) =Idea or Concept =URLScheme;
| - 361. MAL HISTIOCYTOSIS SPLEEN
- [ ] (UMLS (ICD9CM) C0432544) =Neoplastic Process
|
- 312. Main Bronchus
- (UMLS (NCI) C0024496) =Body Part, Organ, or Organ Component ;
| - 362. MAL HISTIOCYTOSIS THORAX
- [ ] (UMLS (ICD9CM) C0432539) =Neoplastic Process
|
- 313. Maine
- [A state in the northeastern United States. Its capital is Augusta. ( NCI )] (UMLS (NCI) C0024497) =Geographic Area ;
| - 363. MAL HYP HT DIS W/O HF
- [ ] (UMLS (ICD9CM) C1135328) Malignant hypertensive heart disease without heart failure =Disease or Syndrome ;
|
- 314. mainframe computer
- [a large, fast computer whose capacity will support multiple, simultaneous users and applications; it is the largest type of computer. ( CSP )] (UMLS (CSP) C0009626) =Manufactured Object ;
=computer hardware; | - 364. MAL HYPERT HRT DIS W HF
- [ ] (UMLS (ICD9CM) C1135329) Malignant hypertensive heart disease with heart failure =Disease or Syndrome ;
|
- 315. Maintain
- [The act of sustaining something in its current form or proper condition; upkeep. ( NCI )] (UMLS (NCI) C0024501) =Activity ;
| - 365. MAL MASTOCYTOSIS ABDOM
- [ ] (UMLS (ICD9CM) C0153844) =Neoplastic Process
|
- 316. maintained entity
- [An entity (player) that is maintained by another entity (scoper). This is typical role held by durable equipment. The scoper assumes responsibility for proper operation, quality, and safety. ( HL7V3.0 )] (UMLS (HL7) C1550599) =Idea or Concept =RoleClassPassive;
| - 366. MAL MASTOCYTOSIS AXILLA
- [ ] (UMLS (ICD9CM) C0153845) =Neoplastic Process
|
- 317. maintenance therapy
- [Treatment that is given to help a primary (original) treatment keep working. Maintenance therapy is often given to help keep cancer in remission. ( NCI )] (UMLS (NCI) C0677908) =Therapeutic or Preventive Procedure ;
| - 367. MAL MASTOCYTOSIS HEAD
- (UMLS (ICD9CM) C0686574) =Neoplastic Process
|
- 318. maize chlorotic dwarf virus
- [ ] (UMLS (CSP) C0599363) =Virus ;
| - 368. MAL MASTOCYTOSIS INGUIN
- [ ] (UMLS (ICD9CM) C0153846) =Neoplastic Process
|
- 319. maize rough dwarf virus
- [ ] (UMLS (CSP) C0599311) =Virus ;
| - 369. MAL MASTOCYTOSIS MULT
- [ ] (UMLS (ICD9CM) C0153849) =Neoplastic Process
|
- 320. Major
- [Greater or bigger in amount, extent, or size. ( NCI )] (UMLS (NCI) C0205164) =Qualitative Concept
| - 370. MAL MASTOCYTOSIS PELVIC
- [ ] (UMLS (ICD9CM) C0153847) =Neoplastic Process
|
- 321. Major abnormality of bony pelvis, not further specified, antepartum
- [ ] (UMLS (ICD9CM) C0156968) =Acquired Abnormality; Disease or Syndrome
| - 371. MAL MASTOCYTOSIS SPLEEN
- [ ] (UMLS (ICD9CM) C0153848) =Neoplastic Process
|
- 322. Major abnormality of bony pelvis, not further specified, delivered
- [ ] (UMLS (ICD9CM) C0156967) =Acquired Abnormality; Disease or Syndrome
| - 372. MAL MASTOCYTOSIS THORAX
- [ ] (UMLS (ICD9CM) C0153843) =Neoplastic Process
|
- 323. Major abnormality of bony pelvis, not further specified, in pregnancy, labor, and delivery
- [ ] (UMLS (ICD9CM) C0269713) =Anatomical Abnormality
| - 373. MAL MELANOM FACE NEC/NOS
- [ ] (UMLS (ICD9CM) C0153532) =Neoplastic Process
|
- 324. Major abnormality of bony pelvis, not further specified, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156966) =Acquired Abnormality; Disease or Syndrome
| - 374. MAL MELANOMA SCALP/NECK
- (UMLS (ICD9CM) C0346782) =Neoplastic Process
|
- 325. Major anomalies of jaw size
- (UMLS (ICD9CM) C0024508) =Congenital Abnormality ;
| - 375. MAL NEO ABDOMIN ESOPHAG
- [A primary or metastatic malignant neoplasm involving the abdominal region of the esophagus. ( NCI )] (UMLS (ICD9CM) C0496775) =Neoplastic Process
|
- 326. major depression
- [one or more periods of depression in the absence of history of manic or hypomanic episodes; chronic type lasts 2 or more years; melancholic type is more severe, has vegetative signs, and responds well to somatic therapy. ( CSP )] (UMLS (CSP) C1269683) =Mental or Behavioral Dysfunction =clinical depression;
PSYCHOSES | - 376. MAL NEO ACCESS SINUS NEC
- (UMLS (ICD9CM) C0153480) =Neoplastic Process
|
- 327. Major Depression
- [A mood disorder having a clinical course involving one or more episodes of serious psychological depression that last two or more weeks each, do not have intervening episodes of mania or hypomania, and are characterized by a loss of interest or pleasure in almost all activities and by some or all of disturbances of appetite, sleep, or psychomotor functioning, a decrease in energy, difficulties in thinking or making decisions, loss of self-esteem or feelings of guilt, and suicidal thoughts or attempts. ( NCI )] (UMLS (NCI) C0041696) =Mental or Behavioral Dysfunction
| - 377. MAL NEO ACCESS SINUS NOS
- [A primary or metastatic malignant neoplasm involving the paranasal sinuses. ( NCI )] (UMLS (ICD9CM) C0153474) =Neoplastic Process
|
- 328. Major depressive disorder, recurrent episode
- [ ] (UMLS (ICD9CM) C0154409) =Mental or Behavioral Dysfunction
| - 378. MAL NEO ADNEXA NEC
- (UMLS (ICD9CM) C0153583) =Neoplastic Process
|
- 329. Major depressive disorder, recurrent episode, in full remission
- [ ] (UMLS (ICD9CM) C0154415) =Mental or Behavioral Dysfunction
| - 379. MAL NEO ADNEXA NOS
- (UMLS (ICD9CM) C0153584) =Neoplastic Process
|
- 330. Major depressive disorder, recurrent episode, in partial or unspecified remission
- [ ] (UMLS (ICD9CM) C0338893) =Mental or Behavioral Dysfunction
| - 380. MAL NEO AMPULLA OF VATER
- [A primary or metastatic malignant neoplasm involving the ampulla of Vater. ( NCI )] (UMLS (ICD9CM) C0153454) =Neoplastic Process
|
- 331. Major depressive disorder, recurrent episode, mild degree
- [ ] (UMLS (ICD9CM) C0154410) =Mental or Behavioral Dysfunction
| - 381. MAL NEO ANT 2/3 TONGUE
- (UMLS (ICD9CM) C0153354) =Neoplastic Process
|
- 332. Major depressive disorder, recurrent episode, moderate degree
- [ ] (UMLS (ICD9CM) C0154411) =Mental or Behavioral Dysfunction
| - 382. MAL NEO ANT EPIGLOTTIS
- (UMLS (ICD9CM) C0496765) =Neoplastic Process
|
- 333. Major depressive disorder, recurrent episode, severe degree, specified as with psychotic behavior
- [ ] (UMLS (ICD9CM) C0154413) =Mental or Behavioral Dysfunction
| - 383. MAL NEO ANT FLOOR MOUTH
- (UMLS (ICD9CM) C0153369) =Neoplastic Process
|
- 334. Major depressive disorder, recurrent episode, severe degree, without mention of psychotic behavior
- [ ] (UMLS (ICD9CM) C0154412) =Mental or Behavioral Dysfunction
| - 384. MAL NEO ANT MEDIASTINUM
- [ ] (UMLS (ICD9CM) C0153501) =Neoplastic Process
|
- 335. Major Diagnostic Category
- (UMLS (HL7) C1550395) =Classification =HL7 Vocabulary Version 2.5;
| - 385. MAL NEO ANT NASOPHARYNX
- (UMLS (ICD9CM) C0153396) =Neoplastic Process
|
- 336. major histocompatibility complex
- [genetic region found in all mammals whose products are primarily reponsible for the rapid rejection of grafts between individuals and which signal between lymphocytes and cells expressing antigen; H-2 in mouse and HLA in humans. ( CSP )] (UMLS (CSP) C0024518) =Gene or Genome ;
=histocompatibility gene; | - 386. MAL NEO ARYEPIGLOTT FOLD
- (UMLS (ICD9CM) C0153401) =Neoplastic Process
|
- 337. Major Histocompatibility Complex Gene
- [A group of linked loci, collectively termed H-2 complex in the mouse and HLA complex in humans, that codes for cell-surface histocompatibility antigens and is the principal determinant of tissue type and transplant compatibility. ( NCI )] (UMLS (NCI) C1334545) =Gene or Genome
| - 387. MAL NEO BLADDER NECK
- (UMLS (ICD9CM) C0153613) =Neoplastic Process
|
- 338. Major Histocompatibility Complex Receptor
- [immunoglobulin like receptor associated with CD3 marker on T lymphocytes which binds specific antigen and thereby participates in T cell activation; recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen receptor structure, composed of either alpha-beta or gamma-delta chains. ( CSP )] (UMLS (NCI) C0034790) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =antigen receptor;
| - 388. MAL NEO BLADDER-ANTERIOR
- (UMLS (ICD9CM) C0153611) =Neoplastic Process
|
- 339. Major Late Transcription Factor 1
- [Ubiquitously expressed by human USF1 Gene, 310-aa 34-kDa nuclear Upstream Stimulatory Factor 1 is a bHLH transcription factor that binds to symmetrical E-box DNA (CACGTG) in viral and cellular promoters as a homodimer or USF1/USF2 heterodimer (USF). Efficient DNA binding requires dimerization with another bHLH protein and USF1 can act synergistically with GTF2I to activate transcription. Direct GTF2I interaction requires the USF1 activation and dimerization domains. USF1/USF2A heterodimer represents most USF binding activity. (NCI) ( NCI )] (UMLS (NCI) C1451716) Upstream Stimulatory Factor 1;
USF1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ; | - 389. MAL NEO BLADDER-POST
- (UMLS (ICD9CM) C0153612) =Neoplastic Process
|
- 340. Major medical
- (UMLS (HL7) C1549486) =Idea or Concept =Policy type;
| - 390. MAL NEO BLADDER-TRIGONE
- [ ] (UMLS (ICD9CM) C0496826) =Neoplastic Process
|
- 341. Major Operative
- (UMLS (HL7) C1547206) =Idea or Concept =Procedure DRG Type;
| - 391. MAL NEO BODY UTERUS NEC
- (UMLS (ICD9CM) C0153576) =Neoplastic Process
|
- 342. MAJOR OSSEOUS DEFECTS
- [ ] (UMLS (ICD9CM) C1719624) =Disease or Syndrome
| - 392. MAL NEO BONES ANKLE/FOOT
- [ ] (UMLS (ICD9CM) C0153518) =Neoplastic Process
|
- 343. MAJOR PUERP INF-DEL P/P
- [ ] (UMLS (ICD9CM) C0157491) =Disease or Syndrome ;
| - 393. MAL NEO BONES WRIST/HAND
- [ ] (UMLS (ICD9CM) C0153515) =Neoplastic Process
|
- 344. MAJOR PUERP INF-POSTPART
- [ ] (UMLS (ICD9CM) C0375477) =Disease or Syndrome
| - 394. MAL NEO BRAIN STEM
- (UMLS (ICD9CM) C0153641) =Neoplastic Process
|
- 345. MAJOR PUERP INFECT-UNSP
- [ ] (UMLS (ICD9CM) C0375476) =Disease or Syndrome
| - 395. MAL NEO BREAST LOW-INNER
- [ ] (UMLS (ICD9CM) C0153551) =Neoplastic Process
|
- 346. Major puerperal infection
- [ ] (UMLS (ICD9CM) C0157489) =Disease or Syndrome ;
| - 396. MAL NEO BREAST LOW-OUTER
- [ ] (UMLS (ICD9CM) C0153553) =Neoplastic Process
|
- 347. Major Salivary Gland
- (UMLS (NCI) C0930553) =Body Part, Organ, or Organ Component
| - 397. MAL NEO BREAST UP-INNER
- [ ] (UMLS (ICD9CM) C0153550) =Neoplastic Process
|
- 348. Major Salivary Gland Mucoepidermoid Carcinoma
- [Mucoepidermoid carcinomas are the most frequent malignancy in major salivary glands, especially the parotid gland. ( NCI )] (UMLS (NCI) C1334551) Mucoepidermoid Carcinoma of Major Salivary Gland;
Mucoepidermoid Carcinoma of the Major Salivary Gland =Neoplastic Process | - 398. MAL NEO BREAST UP-OUTER
- [ ] (UMLS (ICD9CM) C0153552) =Neoplastic Process
|
- 349. Major Salivary Gland Neoplasm
- (UMLS (NCI) C0345599) =Neoplastic Process
| - 399. MAL NEO BREAST-AXILLARY
- [ ] (UMLS (ICD9CM) C0153554) =Neoplastic Process
|
- 350. Major Salivary Gland Non-Hodgkin Lymphoma
- (UMLS (NCI) C1334552) Major Salivary Gland Non-Hodgkin's Lymphoma;
Non-Hodgkin's Lymphoma of Major Salivary Gland; Non-Hodgkin's Lymphoma of the Major Salivary Gland; Primary Major Salivary Gland Non-Hodgkin's Lymphoma =Neoplastic Process | - 400. MAL NEO BREAST-CENTRAL
- [ ] (UMLS (ICD9CM) C0153549) =Neoplastic Process
|